Chandru Ramana
About Chandru Ramana
Chandru Ramana is a Research Associate II specializing in Bioassay and Process Development at Nektar Therapeutics since 2021. He has a background in biological sciences, with experience in various research roles and a Master's degree in Biotechnology from the University of San Francisco.
Work at Nektar Therapeutics
Chandru Ramana currently serves as a Research Associate II in Bioassay and Process Development at Nektar Therapeutics. He has been with the company since 2021 and operates in the San Francisco Bay Area. In this role, he focuses on the development and optimization of bioassays, contributing to the advancement of therapeutic products.
Previous Experience in Biotechnology
Prior to his current position, Chandru Ramana worked at RAPT Therapeutics as a Research Associate in Quantitative Biology from 2019 to 2021. He also held the position of Biotechnology Lab Assistant at the University of San Francisco for five months in 2018. His earlier roles include an Undergraduate Student Research Intern at Mayo Clinic in 2015 and a T-Cell Research Associate Intern at Xcell Biosciences in 2018.
Education and Expertise
Chandru Ramana earned a Bachelor of Science in Biological and Biomedical Sciences from Minnesota State University, Mankato, where he studied from 2012 to 2016. He later obtained a Master of Science in Biotechnology from the University of San Francisco in 2019. His expertise includes mammalian cell culture and quantitative PCR (qPCR) techniques.
Background in Academic Support and Research
Chandru Ramana has a background in academic support roles, having served as an Anatomy Peer Tutor and Maverick Mentor at Minnesota State University, Mankato from 2014 to 2016. He also worked as a Student Researcher at the same institution during this time. These experiences contributed to his foundational knowledge in the biological sciences.
Career Aspirations in Biotechnology
Chandru Ramana aims to gain more exposure to the quality and regulatory aspects of biotechnology. He seeks to bridge the gap between the business and scientific sides of the industry, reflecting his interest in the multifaceted nature of biotechnology.